Scarica l'app Stockscreener
2.53
0.00%
0.00
Dopo l'orario di chiusura:
2.52
-0.010
-0.40%
Precedente Chiudi:
$2.53
Aprire:
$2.54
Volume 24 ore:
234.96K
Relative Volume:
0.31
Capitalizzazione di mercato:
$73.76M
Reddito:
-
Utile/perdita netta:
$-75.52M
Rapporto P/E:
-0.9731
EPS:
-2.6
Flusso di cassa netto:
$-56.92M
1 W Prestazione:
-3.80%
1M Prestazione:
+6.75%
6M Prestazione:
-87.70%
1 anno Prestazione:
-82.54%
Intervallo 1D:
$2.53
$2.64
Intervallo di 1 settimana:
$2.53
$2.69
Portata 52W:
$1.25
$32.41
Aerovate Therapeutics Inc Stock (AVTE) Company Profile
Nome
Aerovate Therapeutics Inc
Settore
Industria
Telefono
617-443-2400
Indirizzo
930 WINTER STREET, WALTHAM
Confronta AVTE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| AVTE | 2.53 | 73.76M | 0 | -75.52M | -56.92M | -2.60 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Aerovate Therapeutics Inc Stock (AVTE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-03-01 | Iniziato | Guggenheim | Buy |
| 2022-12-06 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-09-19 | Ripresa | Wedbush | Outperform |
| 2022-08-16 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-02-11 | Iniziato | BTIG Research | Buy |
| 2021-07-26 | Iniziato | Cowen | Outperform |
| 2021-07-26 | Iniziato | Evercore ISI | Outperform |
| 2021-07-26 | Iniziato | Jefferies | Buy |
| 2021-07-26 | Iniziato | Wedbush | Outperform |
Mostra tutto
Aerovate Therapeutics Inc Borsa (AVTE) Ultime notizie
GSA Capital Partners LLP Purchases 287,163 Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - MarketBeat
Short Interest in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Declines By 17.3% - MarketBeat
Wedbush Research Analysts Raise Earnings Estimates for AVTE - Defense World
What is Wedbush's Forecast for AVTE FY2024 Earnings? - MarketBeat
Aerovate Therapeutics Reports Q3 Loss Amid Strategic Shift - TipRanks
Finansavisen - Finansavisen
Jade Biosciences’ Merger with Aerovate Therapeutics - Global Legal Chronicle
INVESTOR ALERT: The M&A Class Action Firm Investigates the Merger of Aerovate Therapeutics, Inc. – AVTE - GlobeNewswire Inc.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATSG, STAF, AVTE on Behalf of Shareholders - Marketscreener.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Air Transport Services Group, Inc. (Nasdaq– ATSG), Micropac Industries, Inc. (OTC – MPAD), Aerovate Therapeutics, Inc. (Nasdaq – AVTE), Outbrain Inc. (Nasd - ForexTV.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerovate Therapeutics, Inc.AVTE - Marketscreener.com
INVESTOR ALERT: The M&A Class Action Firm Investigates the Merger of Aerovate Therapeutics, Inc.AVTE - PR Newswire
Aerovate Therapeutics Enters into Merger Agreement with Jade Biosciences - Defense World
How Fairmount’s Paragon incubator steered two more companies to NASDAQ - BioCentury
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE and PFIE on Behalf of Shareholders - Marketscreener.com
Kuehn Law Encourages OB, AVTE, B, and MNTX Investors to Contact Law Firm - The Malaysian Reserve
SEC Form 425 filed by Aerovate Therapeutics Inc. - Quantisnow
Form 425 Aerovate Therapeutics, Filed by: Aerovate Therapeutics, Inc. - StreetInsider.com
Aerovate (AVTE) Shares Rally As Market Responds To A Merger Agreement - Stocks Telegraph
Jade, another biotech spinout of Paragon, to merge with Aerovate - BioPharma Dive
Jade Biosciences and Aerovate announce merger deal - Investing.com
AVTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aerovate Therapeutics, Inc. Is Fair to Shareholders - Business Wire
Aerovate to Merge With Jade Biosciences, Pursue Kidney Treatment - MarketWatch
Shareholder Alert: Ademi LLP Investigates Whether Aerovate Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire
Aerovate climbs on all-stock merger deal with Jade - MSN
Aerovate stock rises on all-stock merger deal (AVTE:NASDAQ) - Seeking Alpha
Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement - GlobeNewswire
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Down 21.4% in October - MarketBeat
Aerovate Therapeutics regains Nasdaq compliance - Investing.com India
Aerovate Therapeutics regains Nasdaq compliance By Investing.com - Investing.com Canada
Hypertension Clinical Trials 2024: FDA Approvals, Medication, Therapies, MOA, ROA, Companies by DelveInsight | Quantum Genomics, CinCor Pharma, Mineralys Therapeutics, Alnylam Therapeutics, Novartis - The Globe and Mail
Cubist Systematic Strategies LLC Makes New Investment in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Analyzing Aerovate Therapeutics Inc (AVTE) After Recent Trading Activity - Knox Daily
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Update - MarketBeat
Aerovate Therapeutics announces board member resignation - Investing.com India
Aerovate Therapeutics announces board member resignation By Investing.com - Investing.com UK
XTX Topco Ltd Invests $35,000 in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Short Interest in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Decreases By 15.7% - MarketBeat
Bank of New York Mellon Corp Increases Stake in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Deerfield Management Company L.P. Series C Takes Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Deerfield Management Company L.P. Series C Acquires New Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - MarketBeat
Affinity Asset Advisors LLC Makes New $332,000 Investment in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Market Highlights: Alector Inc (ALEC) Ends on a Low Note at 5.45 - The Dwinnex
AlgoTx completes pivotal phase 2 trial for ground-breaking CIPN treatment - PharmaTimes
Why AeroVironment Shares Are Flying Higher Today - sharewise
Alector (NASDAQ:ALEC) Shares Down 5.6% - Defense World
Defense Stock Soars on ‘Rare Move’ From the U.S. Army - Barron's
AeroVironment (NASDAQ:AVAV) Shares Gap Up to $182.76 - Defense World
AeroVironment Stock Is Rising Monday: What's Driving The Action? - Benzinga
Altitude Group’s AGM: Mixed Shareholder Decisions - TipRanks
Aerovate Therapeutics Inc Azioni (AVTE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.66%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):